Search research articles
Contact Us
Filters
Showing results (51-60 of 93) with videos related to
Page
of 10
Sort By:
The Journal of Thoracic and Cardiovascular Surgery
|
February 25, 2023
Safety of adjuvant atezolizumab after pneumonectomy/bilobectomy in stage II-IIIA non-small cell lung cancer in the randomized phase III IMpower010 trial
Jay M Lee, Eric Vallières, Beiying Ding, et al.
American Journal of Translational Research
|
June 10, 2011
Elevated levels of CXC chemokine connective tissue activating peptide (CTAP)-III in lung cancer patients
Gina Lee, Brian K Gardner, David A Elashoff, et al.
Journal of Translational Medicine
|
July 23, 2008
Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in non-small cell lung cancer
Felicita Baratelli, Hiroko Takedatsu, Saswati Hazra, et al.
JTO Clinical and Research Reports
|
November 22, 2021
Technical Feasibility and Safety of Repeated Computed Tomography-Guided Transthoracic Intratumoral Injection of Gene-Modified Cellular Immunotherapy in Metastatic NSCLC
Puja Shahrouki, Jay M Lee, Jonathan Barclay, et al.
Immunotargets and Therapy
|
May 3, 2014
Targeting myeloid-derived suppressor cells augments antitumor activity against lung cancer
Minu K Srivastava, Li Zhu, Marni Harris-White, et al.
Clinical Genitourinary Cancer
|
October 9, 2018
Solitary Mucinous Prostate Adenocarcinoma Lung Metastasis Detected by <sup>68</sup>Ga-PSMA-11 PET/CT
Giulia Polverari, Francesco Ceci, Martin Allen-Auerbach, et al.
Journal of Cancer Science & Therapy
|
November 3, 2015
Combination Treatment with Apricoxib and IL-27 Enhances Inhibition of Epithelial-Mesenchymal Transition in Human Lung Cancer Cells through a STAT1 Dominant Pathway
Mi-Heon Lee, Puja Kachroo, Paul C Pagano, et al.
Oncoimmunology
|
July 3, 2015
GITR agonist enhances vaccination responses in lung cancer
Li X Zhu, Michael Davoodi, Minu K Srivastava, et al.
JCI Insight
|
September 22, 2017
Inflammation, oxidative stress, and glial cell activation characterize stellate ganglia from humans with electrical storm
Olujimi A Ajijola, Donald B Hoover, Thomas M Simerly, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 27, 2013
IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer
Puja Kachroo, Mi-Heon Lee, Ling Zhang, et al.
Page
of 10
Search research articles
Search
Showing results (51-60 of 93) with videos related to
Sort By:
Page
of 10
The Journal of Thoracic and Cardiovascular Surgery
|
February 25, 2023
Safety of adjuvant atezolizumab after pneumonectomy/bilobectomy in stage II-IIIA non-small cell lung cancer in the randomized phase III IMpower010 trial
Jay M Lee, Eric Vallières, Beiying Ding, et al.
American Journal of Translational Research
|
June 10, 2011
Elevated levels of CXC chemokine connective tissue activating peptide (CTAP)-III in lung cancer patients
Gina Lee, Brian K Gardner, David A Elashoff, et al.
Journal of Translational Medicine
|
July 23, 2008
Pre-clinical characterization of GMP grade CCL21-gene modified dendritic cells for application in a phase I trial in non-small cell lung cancer
Felicita Baratelli, Hiroko Takedatsu, Saswati Hazra, et al.
JTO Clinical and Research Reports
|
November 22, 2021
Technical Feasibility and Safety of Repeated Computed Tomography-Guided Transthoracic Intratumoral Injection of Gene-Modified Cellular Immunotherapy in Metastatic NSCLC
Puja Shahrouki, Jay M Lee, Jonathan Barclay, et al.
Immunotargets and Therapy
|
May 3, 2014
Targeting myeloid-derived suppressor cells augments antitumor activity against lung cancer
Minu K Srivastava, Li Zhu, Marni Harris-White, et al.
Clinical Genitourinary Cancer
|
October 9, 2018
Solitary Mucinous Prostate Adenocarcinoma Lung Metastasis Detected by <sup>68</sup>Ga-PSMA-11 PET/CT
Giulia Polverari, Francesco Ceci, Martin Allen-Auerbach, et al.
Journal of Cancer Science & Therapy
|
November 3, 2015
Combination Treatment with Apricoxib and IL-27 Enhances Inhibition of Epithelial-Mesenchymal Transition in Human Lung Cancer Cells through a STAT1 Dominant Pathway
Mi-Heon Lee, Puja Kachroo, Paul C Pagano, et al.
Oncoimmunology
|
July 3, 2015
GITR agonist enhances vaccination responses in lung cancer
Li X Zhu, Michael Davoodi, Minu K Srivastava, et al.
JCI Insight
|
September 22, 2017
Inflammation, oxidative stress, and glial cell activation characterize stellate ganglia from humans with electrical storm
Olujimi A Ajijola, Donald B Hoover, Thomas M Simerly, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
November 27, 2013
IL-27 inhibits epithelial-mesenchymal transition and angiogenic factor production in a STAT1-dominant pathway in human non-small cell lung cancer
Puja Kachroo, Mi-Heon Lee, Ling Zhang, et al.
Page
of 10